View in EDS

Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.

Saved in:
Bibliographic Details
Title: Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
Authors: Patel KR; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA., Nguyen PL; Brigham and Women's Hospital, Boston, MA, USA., Proudfoot JA; Veracyte, Inc, South San Francisco, CA, USA., Liu Y; Veracyte, Inc, South San Francisco, CA, USA., Pra AD; University of Miami Cancer Center, Miami, FL, USA., Spratt DE; UH Cleveland Medical Center, Cleveland, OH, USA., Pollack A; University of Miami Cancer Center, Miami, FL, USA., Sandler HM; Cedars-Sinai Medical Center, Los Angeles, CA, USA., Efstathiou JA; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Lawton C; Medical College of Wisconsin, Milwaukee, WI, USA., Simko JP; UCSF Medical Center-Mission Bay, San Francisco, CA, USA., Rosenthal SA; Sutter Cancer Centers Radiation Oncology Services, Roseville, CA, USA., Zeitzer KL; Einstein Medical Center, Accruals for Thomas Jefferson University Hospital, Philadelphia, PA, USA., Mendez LC; London Regional Cancer Program, London, ON, Canada., Hartford AC; Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, Lebanon, NH, USA., Hall WA; Froedtert and the Medical College of Wisconsin, Milwaukee, WI, USA., Desai AB; Summa Health System, Akron, OH, USA., Pugh SL; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; ACR, American College of Radiology, Philadelphia, PA, USA., Davicioni E; Veracyte, Inc, South San Francisco, CA, USA., Tran PT; Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA. Electronic address: phuoc.tran@som.umaryland.edu., Feng FY; UCSF Medical Center-Mission Bay, San Francisco, CA, USA. Electronic address: felix.feng@ucsf.edu.
Source: European urology oncology [Eur Urol Oncol] 2026 Apr; Vol. 9 (2), pp. 413-421. Date of Electronic Publication: 2024 Nov 13.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39542826
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Patel+KR%22">Patel KR</searchLink>; Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+PL%22">Nguyen PL</searchLink>; Brigham and Women's Hospital, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Proudfoot+JA%22">Proudfoot JA</searchLink>; Veracyte, Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; Veracyte, Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pra+AD%22">Pra AD</searchLink>; University of Miami Cancer Center, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Spratt+DE%22">Spratt DE</searchLink>; UH Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pollack+A%22">Pollack A</searchLink>; University of Miami Cancer Center, Miami, FL, USA.<br /><searchLink fieldCode="AU" term="%22Sandler+HM%22">Sandler HM</searchLink>; Cedars-Sinai Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Efstathiou+JA%22">Efstathiou JA</searchLink>; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lawton+C%22">Lawton C</searchLink>; Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Simko+JP%22">Simko JP</searchLink>; UCSF Medical Center-Mission Bay, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rosenthal+SA%22">Rosenthal SA</searchLink>; Sutter Cancer Centers Radiation Oncology Services, Roseville, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zeitzer+KL%22">Zeitzer KL</searchLink>; Einstein Medical Center, Accruals for Thomas Jefferson University Hospital, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Mendez+LC%22">Mendez LC</searchLink>; London Regional Cancer Program, London, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hartford+AC%22">Hartford AC</searchLink>; Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, Lebanon, NH, USA.<br /><searchLink fieldCode="AU" term="%22Hall+WA%22">Hall WA</searchLink>; Froedtert and the Medical College of Wisconsin, Milwaukee, WI, USA.<br /><searchLink fieldCode="AU" term="%22Desai+AB%22">Desai AB</searchLink>; Summa Health System, Akron, OH, USA.<br /><searchLink fieldCode="AU" term="%22Pugh+SL%22">Pugh SL</searchLink>; NRG Oncology Statistics and Data Management Center, Philadelphia, PA, USA; ACR, American College of Radiology, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Davicioni+E%22">Davicioni E</searchLink>; Veracyte, Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tran+PT%22">Tran PT</searchLink>; Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA. Electronic address: phuoc.tran@som.umaryland.edu.<br /><searchLink fieldCode="AU" term="%22Feng+FY%22">Feng FY</searchLink>; UCSF Medical Center-Mission Bay, San Francisco, CA, USA. Electronic address: felix.feng@ucsf.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2026 Apr; Vol. 9 (2), pp. 413-421. <i>Date of Electronic Publication: </i>2024 Nov 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39542826
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.euo.2024.10.017
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 413
    Titles:
      – TitleFull: Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Patel KR
      – PersonEntity:
          Name:
            NameFull: Nguyen PL
      – PersonEntity:
          Name:
            NameFull: Proudfoot JA
      – PersonEntity:
          Name:
            NameFull: Liu Y
      – PersonEntity:
          Name:
            NameFull: Pra AD
      – PersonEntity:
          Name:
            NameFull: Spratt DE
      – PersonEntity:
          Name:
            NameFull: Pollack A
      – PersonEntity:
          Name:
            NameFull: Sandler HM
      – PersonEntity:
          Name:
            NameFull: Efstathiou JA
      – PersonEntity:
          Name:
            NameFull: Lawton C
      – PersonEntity:
          Name:
            NameFull: Simko JP
      – PersonEntity:
          Name:
            NameFull: Rosenthal SA
      – PersonEntity:
          Name:
            NameFull: Zeitzer KL
      – PersonEntity:
          Name:
            NameFull: Mendez LC
      – PersonEntity:
          Name:
            NameFull: Hartford AC
      – PersonEntity:
          Name:
            NameFull: Hall WA
      – PersonEntity:
          Name:
            NameFull: Desai AB
      – PersonEntity:
          Name:
            NameFull: Pugh SL
      – PersonEntity:
          Name:
            NameFull: Davicioni E
      – PersonEntity:
          Name:
            NameFull: Tran PT
      – PersonEntity:
          Name:
            NameFull: Feng FY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2588-9311
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: European urology oncology
              Type: main
ResultId 1